(Q62664175)
Statements
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies (English)
Andrew Futreal
David Olmos
Nina Tunariu
Ruth Riisnaes
Lorna Pope
Jeremy Clark
David Collins
Carol Waghorne
Feng Chai
Edward Garmey
Timothy A Yap
Andre T Brunetto
Nandita M deSouza
Ronald E Savage
Stan B Kaye
Johann S de Bono